Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marisa Bustos"'
Autor:
Catalina Vargas, Cristóbal Maiz, María Elena Navarro, Mauricio Camus, César Sánchez, Marisa Bustos, David Oddó
Publikováno v:
ecancermedicalscience
Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth fac
Autor:
Pablo Muñoz, César Sánchez, Yerko Borghero, Claudia Ortega, Francisco Acevedo, Paula Arriagada, Marisa Bustos, Carolina Ibañez
Publikováno v:
International Cancer Conference Journal. 2:229-233
Systemic treatment for cancer including chemotherapy or biologic agents can cause different changes in the skin or mucous membranes. These changes may represent a known adverse reaction to these drugs, although other etiologies should be considered.
Autor:
Paula Carrasco, Eugenio Vinés, Ramón Baeza Baeza, César García, Bettina Müller, Hans Harbst, Osvaldo Giannini, Pablo González M, Marisa Bustos, Jorge Gallardo, Raúl Cartes
Publikováno v:
Revista médica de Chile v.140 n.8 2012
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Normal.dotm 0 0 1 247 1410 Instituto Oncologico 11 2 1731 12.0 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-nosh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44a6b2c0e47083319b65fef7f0d219b
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000800015
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000800015
Autor:
Pelayo, Besa D C, Roberto, Rosso A, Marisa, Bustos C, Yerko, Borghero, Cristian, Trucco B, Macarena, Mac-Namara H
Publikováno v:
Revista medica de Chile. 139(11)
Intensity modulated radiotherapy (IMRT) is an important step forward in cancer treatment.To report the first experience in Chile with IMRT for prostate cancer and compare the results obtained with different doses.From January 1997 through June 2008,
Autor:
Yerko Borghero, Pelayo Besa Dc, Macarena Mac-Namara H, Marisa Bustos C, Roberto P Rosso A, Cristian Trucco B
Publikováno v:
Revista médica de Chile v.139 n.11 2011
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Intensity modulated radiotherapy (IMRT) is an important step forward in cancer treatment. Aim: To report the first experience in Chile with IMRT for prostate cancer and compare the results obtained with different doses. Patients and Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274d29842f91896537bf7726a631cb90
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100009
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100009
Autor:
Marcelo, Garrido, Marisa, Bustos, Eric, Orellana, Jorge, Madrid, Héctor, Galindo, César, Sánchez, Fernando, Pimentel, Sergio, Guzmán, Luis, Ibáñez, Jean Michel, Butte, Manuel, Alvarez, Pelayo, Besa
Publikováno v:
Revista medica de Chile. 136(7)
Overall 5 years survival for surgically excised gastric cancer is 30%. Adjuvant treatment may improve the surgical results.To assess treatment results and toxicity in patients with surgically excised gastric cancer, treated with adjuvant radiotherapy
Autor:
César Sánchez, Marisa Bustos, Manuel Alvarez, Jean M. Butte, Marcelo Garrido, Luis Ibáñez, Jorge Madrid, Héctor Galindo, Pelayo Besa, Eric Orellana, Fernando Pimentel, Sergio Guzmán
Publikováno v:
Revista médica de Chile v.136 n.7 2008
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Overall 5 years survival for surgically excised gastric cancer is 30%. Adjuvant treatment may improve the surgical results. Aim: To assess treatment results and toxicity in patients with surgically excised gastric cancer, treated with adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f5c111539d0930a3bbb51556df7fe7
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000700004
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000700004
Autor:
César, Sánchez, Marisa, Bustos, Mauricio, Camus, Manuel, Alvarez, Ignacio, Goñi, Augusto, León, Pelayo, Besa de C
Publikováno v:
Revista medica de Chile. 135(4)
Breast cancer will develop in one out of ten women during their lifetime. Early diagnosis has increased in recent years.To describe a population of women with breast cancer stage T1N0M0. To analyze radiation therapy toxicity and to evaluate treatment
Autor:
Manuel Alvarez Z, Marisa Bustos C, Pelayo Besa de C, Mauricio Camus A, César Sánchez R, Ignacio Goñi E, Augusto León R
Publikováno v:
Revista médica de Chile v.135 n.4 2007
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Breast cancer will develop in one out of ten women during their lifetime. Early diagnosis has increased in recent years. Aim: To describe a population of women with breast cancer stage T1N0M0. To analyze radiation therapy toxicity and to
Autor:
Héctor Galindo A, Manuel Alvarez Z, César Sánchez R, Mauricio Camus A, Eric Orellana U, Marisa Bustos C, Pelayo Besa de C
Publikováno v:
Revista chilena de cirugía v.59 n.2 2007
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
El cáncer de mama es la segunda causa de muerte por cáncer en mujeres en Chile. El tratamiento adyuvante con quimioterapia ha demostrado disminuir la recurrencia y muerte por la enfermedad. La recomendación de usar adyuvancia en un paciente indivi